La maladie de Parkinson au Canada (serveur d'exploration)

Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.

Eléments de l'association

Canada7508
E. G. Mcgeer28
Canada Sauf E. G. Mcgeer" 7482
E. G. Mcgeer Sauf Canada" 2
Canada Et E. G. Mcgeer 26
Canada Ou E. G. Mcgeer 7510
Corpus8669
\n\n\n\n \n

List of bibliographic references

Number of relevant bibliographic references: 26.
Ident.Authors (with country if any)Title
002905 J. Miklossy [Canada] ; D. D. Doudet [Canada] ; C. Schwab [Canada] ; S. Yu [Canada] ; E. G. Mcgeer [Canada] ; P. L. Mcgeer [Canada]Role of ICAM-1 in persisting inflammation in parkinson disease and MPTP monkeys
003302 K. Yasojima [Canada] ; W. W. Tourtellotte [États-Unis] ; E. G. Mcgeer [Canada] ; P. L. Mcgeer [Canada]Marked increase in cyclooxygenase-2 in ALS spinal cord: Implications for therapy
003513 J. M. Van Kampen [Canada] ; E. G. Mcgeer [Canada] ; A. Jon Stoessl [Canada]Dopamine transporter function assessed by antisense knockdown in the rat: Protection from dopamine neurotoxicity
003A16 E. G. Mcgeer [Canada] ; P. L. Mcgeer [Canada]The future use of complement inhibitors for the treatment of neurological diseases
003A40 P. L. Mcgeer [Canada] ; E. G. Mcgeer [Canada]Glial cell reactions in neurodegenerative diseases : Pathophysiology and therapeutic interventions
003A43 C. Schwab [Canada] ; H. Akiyama [Japon] ; E. G. Mcgeer [Canada] ; P. L. Mcgeer [Canada]Extracellular neurofibrillary tangles are immunopositive for the 40 carboxy-terminal sequence of β-amyloid protein
003C58 P. L. Mcgeer [Canada] ; C. Schwab [Canada] ; E. G. Mcgeer [Canada] ; R. L. Haddock ; J. C. SteeleFamilial nature and continuing morbidity of the amyotrophic lateral sclerosis-parkinsonism dementia complex of Guam
003C72 C. Schwab [Canada] ; J. C. Steele [Canada] ; E. G. Mcgeer [Canada] ; P. L. Mcgeer [Canada]Amyloid P immunoreactivity precedes C4d deposition on extracellular neurofibrillary tangles
004213 I. Tooyama [Canada, Japon] ; E. G. Mcgeer [Canada] ; T. Kawamata [Canada, Japon] ; H. Kimura [Japon] ; P. L. Mcgeer [Canada]Retention of basic fibroblast growth factor immunoreactivity in dopaminergic neurons of the substantia nigra during normal aging in humans contrast with loss in Parkinson's disease
004242 I. Moroo [Japon] ; T. Yamada [Japon] ; H. Makino [Japon] ; I. Tooyama [Japon] ; P. L. Mcgeer [Canada] ; E. G. Mcgeer [Canada] ; K. Hirayama [Japon]Loss of insulin receptor immunoreactivity from the substantia nigra pars compacta neurons in Parkinson's disease
004301 O. Yasuhara [Canada] ; T. Kawamata ; Y. Aimi ; E. G. Mcgeer ; P. L. McgeerExpression of chromogranin A in lesions in the central nervous system from patients with neurological diseases
004405 T. Yamada [Canada] ; D. B. Calne [Canada] ; H. Akiyama [Japon] ; E. G. Mcgeer [Canada] ; P. L. Mcgeer [Canada]Further observations on Tau-positive glia in the brains with progressive supranuclear palsy
004419 Janice J. Pate [Canada] ; T. Kawamata [Canada] ; T. Yamada [Canada] ; E. G. Mcgeer [Canada] ; K. A. Hewitt [Canada] ; B. J. Snow [Canada] ; T. J. Ruth [Canada] ; D. B. Calne [Canada]Correlation of striatal fluorodopa uptake in the MPTP Monkey with dopaminergic indices
004443 P. L. Mcgeer [Canada] ; E. G. McgeerNeurotransmitters and their receptors in the basal ganglia
004449 I. Tooyama [Canada] ; T. Kawamata [Canada] ; D. Walker [Canada] ; T. Yamada [Canada] ; K. Hanai ; H. Kimura ; M. Iwane ; K. Igarashi ; E. G. Mcgeer [Canada] ; P. L. Mcgeer [Canada]Loss of basic fibroblast growth factor in substantia nigra neurons in Parkinson's disease
004455 B. D. Pate [Canada] ; T. Kawamata ; T. Yamada ; E. G. Mcgeer [Canada] ; K. A. Hewitt [Canada] ; B. J. Snow [Canada] ; T. J. Ruth [Canada] ; D. B. Calne [Canada]Correlation of striatal fluorodopa uptake in the MPTP monkey with dopaminergic indices
004462 K. Mizukawa [Canada] ; E. G. Mcgeer ; P. L. McgeerAutoradiographic study on dopamine uptake sites and their correlation with dopamine levels and their striata from patients with Parkinson disease, alzheimer disease, and neurologically normal controls
004641 T. Yamada [Canada] ; P. L. Mcgeer ; E. G. McgeerLewy bodies in Parkinson's disease are recognized by antibodies to complement proteins
004659 E. G. Mcgeer [Canada] ; E. A. SinghAngiotensin-converting enzyme in cortisal tissue in Alzheimer's and some other neurological diseases
004929 T. Yamada [Canada] ; P. L. Mcgeer [Canada] ; K. G. Baimbridge [Canada] ; E. G. Mcgeer [Canada]Relative sparing in Parkinson's disease of substantia nigra dopamine neurons containing calbindin-D28K
004C23 P. L. Mcgeer [Canada] ; S. Itagaki [Canada] ; E. G. Mcgeer [Canada]Expression of the histocompatibility glycoprotein HLA-DR in neurological disease
004F49 E. G. Mcgeer [Canada] ; M. Norman [Canada] ; B. Boyes [Canada] ; J. O'Kusky [Canada] ; J. Suzuki [Canada] ; P. L. Mcgeer [Canada]Acetylcholine and aromatic amine systems in postmortem brain of an infant with Down's syndrome
005288 E. G. Mcgeer [Canada] ; V. K. Singh [Canada] ; J. Parkinson [Canada] ; U. Scherer [Canada]Effects of morphine on axonal transport in nigrostriatal neurons
005355 E. G. Mcgeer [Canada] ; J. Parkinson [Canada] ; P. L. Mcgeer [Canada]Neonatal enzymic development in the interpeduncular nucleus and surrounding ventral tegmentum
005482 E. G. Mcgeer [Canada] ; H. C. Fibiger [Canada] ; P. L. Mcgeer [Canada] ; V. Wickson [Canada]Aging and brain enzymes
005490 P. L. Mcgeer [Canada] ; E. G. Mcgeer [Canada] ; J. A. Wada [Canada] ; E. Jung [Canada]Effects of globus pallidus lesions and Parkinson's disease on brain glutamic acid decarboxylase

Wicri

This area was generated with Dilib version V0.6.29.
Data generation: Thu May 4 22:20:19 2017. Site generation: Fri Dec 23 23:17:26 2022